Position in JNJ
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$87,751,460
-$1,792,289 QoQ
Shares Held
345,519
-5.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#329
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. JNJ ranks #2 (22.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
74,694 | $89,590,231 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
345,519 | $87,751,460 | |
| 3 | ABBV |
AbbVie Inc.
|
254,843 | $64,128,692 | |
| 4 | NVO |
Novo Nordisk A S
|
1,000,682 | $47,972,695 | |
| 5 | AMGN |
Amgen Inc
|
90,846 | $32,897,153 | |
| 6 | MRK |
Merck & Co., Inc.
|
142,059 | $18,254,581 | |
| 7 | NVS |
Novartis AG
|
89,770 | $14,068,754 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
108,152 | $13,663,923 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $87,751,460 | 345,519 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $89,543,749 | 366,322 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $77,810,923 | 375,989 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $63,660,434 | 343,331 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $46,019,756 | 301,275 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $49,688,483 | 299,617 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $42,206,045 | 291,841 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $42,972,964 | 265,167 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $39,128,347 | 267,709 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $48,184,199 | 304,597 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $50,189,715 | 320,210 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $79,251,674 | 508,839 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $88,867,356 | 536,898 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $85,120,420 | 549,164 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $108,666,777 | 615,153 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $101,861,984 | 623,543 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $114,940,032 | 647,513 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $112,323,766 | 633,774 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $109,084,154 | 637,658 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $103,737,425 | 642,337 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $104,187,671 | 632,437 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $103,962,057 | 632,565 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $96,559,712 | 613,545 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $91,435,098 | 614,153 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $84,199,681 | 598,732 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $75,177,746 | 573,307 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||